期刊文献+

18例老年胰腺癌姑息性治疗效果 被引量:6

Analysis of 18 aged patients with advanced pancreatic cancer treated by palliative therapy
下载PDF
导出
摘要 目的 探讨区域性动脉化疗联合减黄在老年胰腺癌病人治疗中的价值。方法 回顾性分析18例老年胰腺癌病人的临床资料。其中 3例采用手术中经胃网膜右动脉插管化疗 ,余 15例由Seldinger’s术插管化疗。化疗药物有米托蒽醌、顺铂、丝裂霉素、5 -氟尿嘧啶和地塞米松等。 结果 完全缓解 10例 ,部分缓解 7例。平均生存期 11± 5月。结论 区域性动脉化疗联合减黄可有效提高病人生存质量 ,延长生存期 ;介入和埋泵化疗有其各自不同的优点和缺点。 Objective To imvestigate the value of regional arterial chemotherapy combind with biliary drainage in the palliative treatment of aged patients with advanced pancreatic cancer. Methods The clinical data of 18 aged patients with advanced pancreatic cancer were retrospectively analyzed. The regional arterial chemotherapy was performed by drug port in 3 patients and by using the Seldinger's technique in 15 cases. The drugs of chemotherapy included mitoxantrone, cisplatin, mitomycin, 5-Fliorouracil, dexamethasone and so on. Results Complete remission appeared in 10 cases, and partial remission in 7. The median survival time was 11 months. Conclusion Regional arterial chemotherapy combind with biliary drainage may improve the quality of life and survival time of aged patients with advanced pancreatic cancer. Either interventional therapy or chemotherapy with a port has its respective advantage and disadvantage.
出处 《陕西肿瘤医学》 2003年第1期21-22,共2页 ShanXi Oncology Medicine
关键词 胰腺癌 减黄 区域性动脉化疗 治疗 pancreatic cancer biliary drainage regional arterial chemotherapy
  • 相关文献

参考文献5

共引文献19

同被引文献36

  • 1寇志平,张志军,黄琳.动脉灌注健择治疗中晚期胰腺癌[J].现代肿瘤医学,2004,12(3):193-194. 被引量:3
  • 2马清涌,马振华,孟勇.胰腺癌的诊断进展[J].现代肿瘤医学,2004,12(6):497-498. 被引量:9
  • 3张学宏,高玉堂.胰腺癌的流行病学[J].胰腺病学,2005,5(3):180-183. 被引量:6
  • 4李佳睿,刘莹,王大伟.区域性动脉灌注联合化疗治疗晚期胰腺癌20例临床疗效观察[J].吉林医学,2005,26(12):1292-1293. 被引量:2
  • 5胡逸民.立体放射治疗[A].谷铣之.肿瘤放射治疗学[C].北京:北京医科大学、协和医科大学联合出版社,1994.214. 被引量:2
  • 6余同行.胰腺癌[A].刘振华.肿瘤预后学[C].北京:科学技术文献出版社,1995.503. 被引量:2
  • 7Hoffman JP, Lipsitz S, Pisansky T, et al. Phase Ⅱ trial of preoperative radiation therapy and chemotherapy for patiens with localized, respectable adenocarcinoma of the pancreas : An Eastern Cooperative Oncology Group study[J ]. J Clin Oncol, 1998,16 ( 1 ) : 317 - 323 被引量:1
  • 8O' Shaughnessy JA, Wittes RE, Burke G, et al. Commentary concerning demonstration of safety and efficacy of investlgational anticancer agents in climical trials[J]. J Clin Oncol, 1991,9 : 2225 - 2232 被引量:1
  • 9Halm U,Schumann T. Decrease of CA 19 - 9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer[J]. Br J Cancer,2000,82(5) :1013 - 1016 被引量:1
  • 10Juan PA,John PH,Ehica R,et al.Preoperative chemoradiation in the management adenocarcinoma of the body of the pancreas.Am Surg,2002,4 :330-336. 被引量:1

引证文献6

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部